secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASP Isotopes Inc. (ASPI)
CIK:        0001921865
Form:       8-K
Filed at:   2026-04-13T23:59:59+00:00
Accession:  0001477932-26-002140
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud

ASP Isotopes targets first commercial shipments in 2026 and >$300M EBITDA by 2031
--------------------------------------------------------------------------------

- First commercial shipments of Silicon-28, Carbon-14, and Ytterbium-176 expected in Q2–Q3 2026.
- Helium Phase 1 nameplate capacity of 58 MCF/day liquid helium expected by Q3 2026.
- Cash, equivalents, and marketable securities totaled $333M as of Dec 31, 2025.
- Acquired two U.S. radiopharmacies (Florida Oct 2025, South Carolina) for radiopharmaceutical expansion.
- QLE submitted draft S-1 for public listing and signed MOU with large U.S. energy company for enriched uranium.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1921865/000147793226002140/0001477932-26-002140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1921865/000147793226002140/aspi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-002140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer